Research Presentation Sessions: Hybrid, Molecular and Translational Imaging
RPS 206 - PET/MRI, MRS and radiomics
Lectures
1
The more the better? Multiparametric simultaneous 18F-FDG PET/MRI vs DCE-MRI for breast cancer diagnosis
08:00Valeria Romeo, Naples / IT
2
Multiparametric dual timepoint 18F-FDG PET/MRI imaging for lymph node staging in Figo I/II cervical carcinoma
08:00Matthias Weissinger, Tübingen / DE
3
Improving the diagnostic performance of 2HG MR spectroscopy utilising creatine as an internal reference
08:00Dominik Juskanic, Nitra / SK
4
Prognostic significance of 68 gallium fibroblast activation protein inhibitor versus 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastric neoplasm subtypes
08:00Nadezhda Niyarah, Bangalore / IN
5
Assessing radio-chemotherapy response in glioblastoma tumour models using 2H-labeled fumarate and deuterium magnetic resonance spectroscopic imaging
08:00Friederike Hesse, Cambridge / UK
6
ComBat harmonisation of multi-centric 18F-FDG-PET/CT and PET/MRI radiomic data: impact on tissue classification
08:00Doris Leithner, New York / US
7
Fully automated staging via PET-CT of primary Hodgkin Lymphoma using a deep learning approach
08:00Kaspar Ekert, Ulm / DE
8
Radiomic features as biomarkers of soft tissue paediatric sarcomas: results of a PET/MR study
08:00Giulia Fichera, Padova / IT
